Dendreon Corporation was founded
In 1992, Dendreon was founded, and its lead product, Provenge, was an immunotherapy for prostate cancer. Dendreon filed…
In 1992, Dendreon was founded, and its lead product, Provenge, was an immunotherapy for prostate cancer. Dendreon filed…
In 1991, U.S. Senator Alan Cranston (D-Calif.) underwent a state-of-the-art procedure at Stanford University Hospital to attack his…
In 1989, researcher William J. Catalona, MD of Washington University – St. Louis began a study that established…
In February 1986, the U.S. Food and Drug Administration (FDA) approved Hybritech’s Tandem-R PSA assay (P850048) with calibration…
In 1985, nerve-sparing prostatectomy, designed to preserve potency and urinary continence, was introduced. This procedure resulted in markedly…
In 1984, the American Chemical Society (ACS) awarded the Priestley Medal to Linus Pauling ‘for his numerous contributions…
In 1974, the Cancer Center of Wake Forest University (CCCWFU), became a National Cancer Institute (NCI)-designated cancer center….
In 1972, The Wistar Institute was designated the first National Cancer Institute (NCI) Cancer Center in basic research…
On Sept. 21, 1960, FDA officials announced the last remaining major source of the discredited Hoxsey cancer treatment…
In 1941, Charles Huggins discovers that blocking male hormones (by removal of the testicles or administration of estrogens)…